Bode DC - Search Results

1

Investigation of functional and morphological integrity of freshly isolated and cryopreserved human hepatocytes.

Ostrowska A, Bode DC, Pruss J, Bilir B, Smith GD, Zeisloft S. Ostrowska A, et al. Among authors: bode dc. Cell Tissue Bank. 2000;1(1):55-68. doi: 10.1023/A:1010175906791. Cell Tissue Bank. 2000. PMID: 15256968

2

Hypothermic storage of isolated human hepatocytes: a comparison between University of Wisconsin solution and a hypothermosol platform.

Ostrowska A, Gu K, Bode DC, Van Buskirk RG. Ostrowska A, et al. Among authors: bode dc. Arch Toxicol. 2009 May;83(5):493-502. doi: 10.1007/s00204-009-0419-x. Epub 2009 Mar 19. Arch Toxicol. 2009. PMID: 19296088

3

Amyloid-β oligomers have a profound detergent-like effect on lipid membrane bilayers, imaged by atomic force and electron microscopy.

Bode DC, Freeley M, Nield J, Palma M, Viles JH. Bode DC, et al. J Biol Chem. 2019 May 10;294(19):7566-7572. doi: 10.1074/jbc.AC118.007195. Epub 2019 Apr 3. J Biol Chem. 2019. PMID: 30948512 Free PMC article.

4

Copper Redox Cycling Inhibits Aβ Fibre Formation and Promotes Fibre Fragmentation, while Generating a Dityrosine Aβ Dimer.

Gu M, Bode DC, Viles JH. Gu M, et al. Among authors: bode dc. Sci Rep. 2018 Nov 1;8(1):16190. doi: 10.1038/s41598-018-33935-5. Sci Rep. 2018. PMID: 30385800 Free PMC article.

5

Serum Albumin's Protective Inhibition of Amyloid-β Fiber Formation Is Suppressed by Cholesterol, Fatty Acids and Warfarin.

Bode DC, Stanyon HF, Hirani T, Baker MD, Nield J, Viles JH. Bode DC, et al. J Mol Biol. 2018 Mar 30;430(7):919-934. doi: 10.1016/j.jmb.2018.01.008. Epub 2018 Feb 2. J Mol Biol. 2018. PMID: 29409811

6

Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes.

Bode DC, Baker MD, Viles JH. Bode DC, et al. J Biol Chem. 2017 Jan 27;292(4):1404-1413. doi: 10.1074/jbc.M116.762526. Epub 2016 Dec 7. J Biol Chem. 2017. PMID: 27927987 Free PMC article.

7

Comparison of urinary desmosine excretion in patients with chronic obstructive pulmonary disease or cystic fibrosis.

Bode DC, Pagani ED, Cumiskey WR, von Roemeling R, Hamel L, Silver PJ. Bode DC, et al. Pulm Pharmacol Ther. 2000;13(4):175-80. doi: 10.1006/pupt.2000.0245. Pulm Pharmacol Ther. 2000. PMID: 10930356

8

Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5.

Silver PJ, Pagani ED, Dundore RL, de Garavilla L, Bode DC, Bacon ER. Silver PJ, et al. Among authors: bode dc. Eur J Pharmacol. 1998 May 22;349(2-3):263-8. doi: 10.1016/s0014-2999(98)00209-x. Eur J Pharmacol. 1998. PMID: 9671106

9

Zaprinast, but not dipyridamole, reverses hemodynamic tolerance to nitroglycerin in vivo.

De Garavilla L, Pagani ED, Buchholz RA, Dundore R, Bode DC, Volberg ML, Jackson KN, Pratt P, Silver PJ. De Garavilla L, et al. Among authors: bode dc. Eur J Pharmacol. 1996 Oct 10;313(1-2):89-96. doi: 10.1016/0014-2999(96)00505-5. Eur J Pharmacol. 1996. PMID: 8905333

10

In vitro characterization of a novel series of platelet-derived growth factor receptor tyrosine kinase inhibitors.

Sawutz DG, Bode DC, Briggs GM, Reid JR, Canniff P, Caldwell L, Faltynek CR, Miller D, Dunn JA, de Garavilla L, Guiles JW, Weigelt C, Michne W, Treasurywala AM, Silver PJ. Sawutz DG, et al. Among authors: bode dc. Biochem Pharmacol. 1996 Jun 28;51(12):1631-8. doi: 10.1016/0006-2952(96)00112-8. Biochem Pharmacol. 1996. PMID: 8687478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters